RETINA RESEARCH PERMANENT ENDOWMEN… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1976

Legal Domicile

Principal Officer

ARTHUR WILLIS MD

Phone

7137971925

Tax Period

2023-01-01 to 2023-12-31

RETINA RESEARCH PERMANENT ENDOWMENT FUND, founded in 1976, is a community nonprofit in the Medical Research sector that reported $2.1M in total revenue in fiscal year 2023. Revenue fell 29% from the prior year — a significant decline worth monitoring. Expenses of $2.3M exceeded revenue, resulting in a 10% operating deficit.

Mission

TO SUPPORT RETINA RESEARCH FOUNDATION

Program Service Accomplishments

Program 1

Expenses: $2,044,723

FUNDS TRANSFERRED TO RETINA RESEARCH FOUNDATION FOR GENERAL SUPPORT TO FURTHER THE CONDUCT OF RESEARCH FOR THE TREATMENT OF RETINAL DISEASE CAUSING BLINDNESS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $179,000

Program Service Revenue $0

Investment Income $1,875,209

Other Revenue $76,764

TOTAL REVENUE $2,130,973

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $2,044,723

Other Expenses $2,348,209

TOTAL EXPENSES $2,348,209

Year-over-Year Comparison

	2023	2022	Change
Revenue	$2,130,973	$2,984,186	-0.3%
Expenses	$2,348,209	$2,232,993	+0.1%
Net Income	$-217,236	$751,193	-1.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
LYNN A BERNARD JR	DIRECTOR	1.00	Director	$0	$0	$0
PATRICIA K BOYD	DIRECTOR	1.00	Director	$0	$0	$0
PETROS E CARVOUNIS MD	DIRECTOR	1.00	Director	$0	$0	$0
ROSANETTE S CULLEN	DIRECTOR	1.00	Director	$0	$0	$0
JOHN C DAWSON JR	DIRECTOR	1.00	Director	$0	$0	$0
RONALD G GIROTTO	DIRECTOR	1.00	Director	$0	$0	$0
NANCY F JAPHET	DIRECTOR	1.00	Director	$0	$0	$0
JAMES E KEY MD	DIRECTOR	1.00	Director	$0	$0	$0
BETTIE HARDING LEE	DIRECTOR	1.00	Director	$0	$0	$0
BRUCE B MACK	DIRECTOR	1.00	Director	$0	$0	$0
LEWIS H GISSEL III	DIRECTOR	1.00	Director	$0	$0	$0
BEN ORMAN MD	DIRECTOR	1.00	Director	$0	$0	$0
KATHERINE W ORTON	DIRECTOR	1.00	Director	$0	$0	$0
H RICHARD WALTON	DIRECTOR	1.00	Director	$0	$0	$0
JOSEPH W ROYCE	DIRECTOR	1.00	Director	$0	$0	$0
ARTHUR WILLIS MD	DIRECTOR	1.00	Director	$0	$0	$0
R MALCOLM WOOLEY	DIRECTOR	1.00	Director	$0	$0	$0
W MAC JENSEN	DIRECTOR	1.00	Director	$0	$0	$0
LAWRENCE P WASHINGTON	DIRECTOR	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$2,130,973	$2,348,209	$68,193,286	$-217,236
2022	$2,984,186	$2,232,993	$60,776,307	$751,193
2021	$8,036,748	$1,791,322	$70,336,261	$6,245,426
2020	$1,679,004	$1,735,080	$61,323,145	$-56,076
2019	$3,449,981	$1,871,051	$56,667,705	$1,578,930
2018	$2,222,306	$1,289,733	$49,357,586	$932,573

RETINA RESEARCH PERMANENT ENDOWMENT FUND